AArtificial intelligence Read More This Pharma Giant Is Using AI to Dominate Drug DiscoveryFebruary 16, 2026 There’s no denying modern-day artificial intelligence (AI) is doing some pretty cool stuff. But, to say it’s been…
AArtificial intelligence Read More Takeda deepens AI drug discovery push with $1.7 billion Iambic dealFebruary 9, 2026 By Kamal Choudhury Feb 9 (Reuters) – Privately held Iambic said on Monday it has entered a multi-year…
MMedication Read More Marty Makary addresses staff concerns over drug voucher programFebruary 4, 2026 WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
HHealthcare Read More Roche moves obesity drug to pivotal trials after mid-stage successJanuary 27, 2026 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
AArtificial intelligence Read More Schrodinger to offer Eli Lilly’s AI drug discovery platform on its softwareJanuary 9, 2026 By Sneha S K Jan 9 (Reuters) – Schrodinger said on Friday it is collaborating with Eli Lilly…
HHealthcare Read More Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbookDecember 13, 2025 By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
MMedication Read More FDA reviewers didn’t get to vote on first priority voucher drugNovember 21, 2025 WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
HHealthcare Read More Countries used to test drugs often don’t see the approved medicines, study findsNovember 18, 2025 Numerous medicines are not accessible in many of the countries where they were tested before approval by the…
HHealthcare Read More 3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 DrugsNovember 10, 2025 Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…
MMedication Read More New FDA priority review vouchers go to Lilly, Novo, VertexNovember 6, 2025 WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
HHealthcare Read More Eli Lilly, Sarepta, Pfizer, Medicare, Novo: Readout NewsletterOctober 8, 2025 Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
GGenetics Read More Synthetic lethality in cancer drug discovery: challenges and opportunitiesSeptember 11, 2025 Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches…